About VISUfarma
VISUfarma was established in 2016 in Amsterdam, Netherlands, within the pharmaceutical sector. Manufacturing of ophthalmic medicine products is conducted, with operations centered on eye care formulations. The company is led by CEO Fabrizio Giombini. Focus is maintained on production processes for medicinal solutions targeting ocular health. Activities are based in the Netherlands, serving regional markets through standard distribution channels.
- Headquarter Amsterdam, Netherlands
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of VISUfarma
Detailed funding history for VISUfarma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in VISUfarma
VISUfarma has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Lupin and GHO Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Specialist healthcare investment advisory services are provided by GHO Capital.
|
Locked | Locked | Locked | |
|
Pharmaceutical products including generics, biosimilars, and APIs are manufactured.
|
Locked | Locked | Locked |
Investor details for VISUfarma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VISUfarma
Investment portfolio details for VISUfarma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - VISUfarma
Detailed financials for VISUfarma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Visufarma Comparisons
Peer comparison for VISUfarma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of VISUfarma
Detailed competitors of VISUfarma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Visufarma
Complete news archive for VISUfarma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VISUfarma
VISUfarma was founded in 2016.
VISUfarma is headquartered in Amsterdam, Netherlands.
Fabrizio Giombini is the current CEO of VISUfarma.
VISUfarma was established in 2016 in Amsterdam, Netherlands, within the pharmaceutical sector. Manufacturing of ophthalmic medicine products is conducted, with operations centered on eye care formulations. The company is led by CEO Fabrizio Giombini. Focus is maintained on production processes for medicinal solutions targeting ocular health. Activities are based in the Netherlands, serving regional markets through standard distribution channels.
VISUfarma has 2 investors. Key investors include Lupin, and GHO Capital.